Millennium Management
HRMY icon

Millennium Management’s Harmony Biosciences HRMY Stock Holding History

Millennium Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.7M Buy
954,359
+722,663
+312% +$23.7M 0.01% 1308
2025
Q4 		$8.67M Buy
231,696
+27,186
+13% +$894K ﹤0.01% 2415
2025
Q3 		$5.64M Buy
204,510
+175,221
+598% +$6.04M ﹤0.01% 3015
2025
Q2 		$926K Sell
29,289
-49,203
-63% -$1.58M ﹤0.01% 4468
2025
Q1 		$2.61M Buy
78,492
+72,159
+1,139% +$2.59M ﹤0.01% 3529
2024
Q4 		$218K Sell
6,333
-64,478
-91% -$2.22M ﹤0.01% 5259
2024
Q3 		$2.83M Sell
70,811
-236,609
-77% -$8.31M ﹤0.01% 3368
2024
Q2 		$9.27M Buy
307,420
+104,691
+52% +$3.15M ﹤0.01% 2155
2024
Q1 		$6.81M Buy
202,729
+180,294
+804% +$5.79M ﹤0.01% 2546
2023
Q4 		$725K Sell
22,435
-83,265
-79% -$2.32M ﹤0.01% 4399
2023
Q3 		$3.46M Sell
105,700
-382,700
-78% -$13.3M ﹤0.01% 3063
2023
Q2 		$17.2M Buy
488,400
+45,368
+10% +$1.57M 0.01% 1527
2023
Q1 		$14.5M Buy
443,032
+270,102
+156% +$12.3M 0.01% 1613
2022
Q4 		$9.53M Buy
172,930
+144,976
+519% +$7.97M 0.01% 2178
2022
Q3 		$1.24M Buy
+27,954
New +$1.36M ﹤0.01% 4152
2022
Q2 		– Sell
-14,683
Closed -$714K – 7180
2022
Q1 		$714K Buy
14,683
+4,354
+42% +$178K ﹤0.01% 4841
2021
Q4 		$440K Sell
10,329
-43,333
-81% -$1.73M ﹤0.01% 5170
2021
Q3 		$2.06M Sell
53,662
-95,261
-64% -$3.07M ﹤0.01% 3877
2021
Q2 		$4.2M Buy
148,923
+141,270
+1,846% +$4.24M ﹤0.01% 2985
2021
Q1 		$253K Sell
7,653
-137,010
-95% -$4.81M ﹤0.01% 5328
2020
Q4 		$5.23M Sell
144,663
-269,624
-65% -$10.9M ﹤0.01% 2388
2020
Q3 		$14K Buy
+414,287
New +$15.1M 0.02% 1004

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management's HRMY Position: Q1 2026 in Review

Millennium Management increased its Harmony Biosciences (HRMY) stake by 312% in Q1 2026, buying an estimated $23.7M and bringing the position to 954,359 shares worth $26.7M. The position accounts for 0.01% of the portfolio, ranked #1308.

Millennium Management first reported a position in HRMY in Q3 2020 and has held it in 22 quarters since. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Millennium Management held 954,359 shares of Harmony Biosciences worth $26.7M as of Q1 2026.
  • Millennium Management bought 722,663 Harmony Biosciences shares in Q1 2026, an estimated $23.7M.
  • Harmony Biosciences made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1308 holding.
  • Millennium Management first reported a position in Harmony Biosciences in Q3 2020 and has held it in 22 quarters since.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.